Zobrazeno 1 - 9
of 9
pro vyhledávání: '"CARLA M Román-Montes"'
Autor:
Sandra Rajme‐López, Andrea C. Tello‐Mercado, Edgar Ortíz‐Brizuela, Bernardo A. Martínez‐Guerra, Karla M. Tamez‐Torres, Carla M. Román‐Montes, María F. González‐Lara, Alfredo Ponce‐de‐León
Publikováno v:
Cancer Reports, Vol 7, Iss 8, Pp n/a-n/a (2024)
ABSTRACT Background Few studies regarding infectious causes of febrile neutropenia (FN) in Mexico are available. Aims We aimed to describe clinical and microbiological characteristics of FN episodes during induction chemotherapy in adults with acute
Externí odkaz:
https://doaj.org/article/49351eba37a84547bbbf27430837d2da
Autor:
Sandra Rajme-López, Bernardo A. Martinez-Guerra, Carla M. Román-Montes, Karla M. Tamez-Torres, Andrea C. Tello-Mercado, Karen M. Tepo-Ponce, Zurisadai Segura-Ortíz, Abigail López-Aguirre, Orianlid del Rocío Gutiérrez-Mazariegos, Oswaldo Lazcano-Delgadillo, Rafael Nares-López, María F. González-Lara, David Kershenobich-Stalnikowitz, José Sifuentes-Osornio, Alfredo Ponce-de-León, Guillermo M. Ruíz-Palacios
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 11 (2024)
Background: Even though worldwide death rates from coronavirus disease 2019 (COVID-19) have decreased, the threat of disease progression and death for high-risk groups continues. Few direct comparisons between the available severe acute respiratory s
Externí odkaz:
https://doaj.org/article/c0547e16aa294fb6a5a7d20482844b07
Autor:
Carla M. Román-Montes, Lisset Seoane-Hernández, Rommel Flores-Miranda, Andrea Carolina Tello-Mercado, Andrea Rangel-Cordero, Rosa Areli Martínez-Gamboa, José Sifuentes-Osornio, Alfredo Ponce-de-León, Fernanda González-Lara
Publikováno v:
Journal of Fungi, Vol 10, Iss 6, p 429 (2024)
The incidence and distribution of coccidioidomycosis are increasing. Information scarcity is evident in Mexico, particularly in non-endemic zones and specific populations. We compared the treatment and outcomes for patients with isolated pulmonary in
Externí odkaz:
https://doaj.org/article/bfb046bfea774b92a0b42bc58fad09f5
Autor:
Alejandro Quiñonez-Flores, Bernardo A. Martinez-Guerra, Carla M. Román-Montes, Karla M. Tamez-Torres, María F. González-Lara, Alfredo Ponce-de-León, Sandra Rajme-López
Publikováno v:
Antibiotics, Vol 13, Iss 2, p 176 (2024)
Background: First-line treatments for methicillin-susceptible S. aureus (MSSA) bacteraemia are nafcillin, oxacillin, or cefazolin. Regional shortages of these antibiotics force clinicians to use other options like dicloxacillin and cephalotin. This s
Externí odkaz:
https://doaj.org/article/adf38a00cfb341e089ef24d89886bd5e
Autor:
Carla M. Román-Montes, Saúl Bojorges-Aguilar, Paulette Díaz-Lomelí, Axel Cervantes-Sánchez, Andrea Rangel-Cordero, Areli Martínez-Gamboa, José Sifuentes-Osornio, Alfredo Ponce-de-León, Maria F. González-Lara
Publikováno v:
Frontiers in Fungal Biology, Vol 3 (2022)
Among critically ill patients, COVID-19-associated pulmonary aspergillosis (CAPA) is a challenging complication. The recommended diagnostic methods for this disease are bronchoalveolar lavage (BAL) culture and galactomannan (GM) testing, which were n
Externí odkaz:
https://doaj.org/article/0c343e582c7d489d964421efb305e437
Autor:
Bernardo A. Martinez-Guerra, Carla Medrano-Borromeo, María F. González-Lara, Carla M. Román-Montes, Karla M. Tamez-Torres, Sandra Rajme-López, Karla D. Salgado-Guízar, Noe A. Juárez-Menéndez, Pilar Ramos-Cervantes, Guillermo M. Ruiz-Palacios, Alfredo Ponce-de-León, José Sifuentes-Osornio
Publikováno v:
Revista de Investigación Clínica, Vol 74, Iss 5 (2022)
Background: Prognostic factors in previously healthy young patients with COVID-19 remained understudied. Objective: The objective of the study was to identify factors associated with in-hospital death or need for invasive mechanical ventilation (IMV)
Externí odkaz:
https://doaj.org/article/49d3070760cf4e39aa088ef733f0c08c
Autor:
Bernardo A. Martinez-Guerra, Nereyda A. de-León-Cividanes, Karla M. Tamez-Torres, Carla M. Román-Montes, Sandra Rajme-López, Edgar Ortiz-Brizuela, Carlos A. Aguilar-Salinas, Juan Sierra-Madero, José Sifuentes-Osornio, Alfredo Ponce-de-León, María F. González-Lara
Publikováno v:
Revista de Investigación Clínica, Vol 74, Iss 1 (2022)
Background: Trials evaluating safety and efficacy of tocilizumab in coronavirus disease 19 (COVID-19) show contradictory results. Objective: The objective of the study was to evaluate the effect of tocilizumab in hospital mortality among patients wit
Externí odkaz:
https://doaj.org/article/ded12b383dfb467d80c0d85ae6ccc718
Autor:
ANA KAREN PEÑAFIEL VICUÑA, MARCO Yamazaki-Nakashimada, Ximena León-Lara, ELIZABETH MENDIETA FLORES, MARÍA ENRIQUETA NUÑEZ NUÑEZ, JUAN CARLOS LONA-REYES, LETICIA HERNADEZ NIETO, MARÍA GUADALUPE RAMÍREZ VÀZQUEZ, JOEL BARROSO SANTOS, ALVARO LÓPEZ IÑIGUEZ, YOLANDA GONZÁLEZ, MARTHA TORRES, JOSÉ LUIS LEZANA FERNANDEZ, CARLA M Román-Montes, EDGAR ALEJANDRO MEDINA-TORRES, EDITH GONZÁLEZ SERRANO, JUAN CARLOS BUSTAMANTE OGANDO, SAUL LUGO REYES, OSCAR ZAVALETA MARTÍNEZ, AIDÉ TAMARA SATINES BOONE, EDNA VENEGAS MONTOYA, NANCY EVELYN AGUILAR GOMEZ, CAMILLE SOUDEÉ, EMMANUELLE JOUANGUY, ANNE PUEL, Stéphanie Boisson-Dupuis, SIFREDO PEDRAZA SÁNCHEZ, JEAN LAURENT CASANOVA, FRANCISCO ESPINOSA ROSALES, SARA Espinosa- Padilla, Jacinta Bustamante, Lizbeth Blancas-Galicia
Publikováno v:
Journal of Clinical Immunology. 43:123-135
BACKGROUND. Mendelian susceptibility to mycobacterial disease (MSMD) is a rare genetic disorder with impaired immunity against intracellular pathogens, such as mycobacteria, attenuated Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) vaccine strai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21bde17567dbe9f70f3d45628f4e4674
https://doi.org/10.1007/s10875-022-01357-8
https://doi.org/10.1007/s10875-022-01357-8
Autor:
Sandra Rajme-López, Bernardo A Martinez-Guerra, Jessica Zalapa-Soto, Carla M Román-Montes, Karla M Tamez-Torres, María F González-Lara, Thierry Hernandez-Gilosul, David Kershenobich-Stalnikowitz, José Sifuentes-Osornio, Alfredo Ponce-de-León, Guillermo M Ruíz-Palacios
Publikováno v:
Open Forum Infectious Diseases. 9
Background Early treatment of coronavirus disease 2019 (COVID-19) with remdesivir in high-risk patients, including those with immunosuppression of different causes, has not been evaluated. The objective of this study was to assess the clinical effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4cb9791570d2f7d9d6c1d7ace9f949d
https://doi.org/10.1093/ofid/ofac502
https://doi.org/10.1093/ofid/ofac502